Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

5.65
Delayed Data
As of Aug 28
 +0.17 / +3.10%
Today’s Change
4.58
Today|||52-Week Range
10.26
-26.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash168.5M7.9M8.3M291.4M
 
 
 
 
 
Short Term Investment Cash-43.0M-37.3M-36.9M197.1M
 
 
 
 
 
Cash & Short Term Investments210.8M168.7M99.5M293.7M
 
 
 
 
 
 
ReceivablesReceivables600.0K7.9M313.0K57.9M
 
 
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsPrepaid Expenses8.3M3.4M1.9M--
 
 
 
 
Other Current Assets13.8M3.1M6.0M4.3M
 
 
 
 
 
Current Assets233.5M183.0M107.7M355.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross9.1M9.2M9.2M9.2M
 
 
 
 
 
Depreciation-9.1M-9.1M-9.2M-9.2M
 
 
 
 
 
Intangible Assets0.00--235.7M259.2M
 
 
 
Other Assets7.4M6.7M235.7M267.0M
 
 
 
 
 
Total Assets269.5M280.0M544.0M962.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable528.0K1.1M287.0K318.0K
 
 
 
 
 
Short Term Debt93.4M0.00395.3M175.5M
 
 
 
 
Accrued Expenses32.7M8.8M11.0M7.5M
 
 
 
 
 
Other Current Liabilities37.7M8.8M11.0M7.5M
 
 
 
 
 
Other Liabilities133.0M10.5M407.4M188.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt316.6M310.0M0.00276.2M
 
 
 
 
Deferred Taxes-11.5M-4.6M-6.7M-33.8M
 
 
 
 
 
Other Liabilities11.3M27.7M23.0M37.7M
 
 
 
 
 
Total Liabilities473.7M348.1M430.5M501.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-204.3M-68.1M113.5M460.4M
 
 
 
 
 
Total Shareholder Equity-204.3M-68.1M113.5M460.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding139.7M139.8M139.9M162.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.